When ImmunoBrain announced that Dr. Rochelle Walensky would be joining its board of directors, the news was delivered with the usual optimism that accompanies biotech leadership shake-ups. Walensky, best known as the former director of the U.S. Centers for Disease Control and Prevention, is stepping into the world of Alzheimer’s […]